Back to results
US 2024/0374679 A1Published application
Interleukin-18 mimics and methods of use
AssigneeYale University
InventorAaron Ring
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods of making and methods of using IL-18 mimic polypeptides for use in therapeutic and non-therapeutic applications. The synthetic IL-18 mimics an increase IL-18R signaling activity even in the presence of an inhibitory molecule such as IL-18BP.
Claims19
1-40. (canceled)
A method of making a nucleic acid encoding a mimic of a parent interleukin 18 (IL-18) protein, the method comprising:
- (a) computationally designing a polypeptide de novo from a parent IL-18 protein by:
- (i) defining as a template a structure of the IL-18 parent protein in a complex with at least human IL-18Rα, wherein the parent IL-18 protein is a decoy resistant (DR) IL-18 variant polypeptide of wild-type (WT) human IL-18;
- (ii) designating one or more hotspots in the template based on binding sites in the complex;
- (iii) inputting the template comprising the one or more designated hotspots into a mimetic design protocol to generate a de novo polypeptide backbone;
- and
- (iv) outputting an amino acid sequence for the de novo designed polypeptide;
- and
- (b) producing a nucleic acid that encodes the amino acid sequence for the de novo designed polypeptide that was computationally designed in step (a), wherein the amino acid sequence has 84% or less sequence identity with WT human IL-18 SEQ ID NO:30, has a beta trefoil fold, specifically binds to human IL-18 receptor (IL-18R), and exhibits substantially reduced binding to human IL-18 binding protein (IL-18BP) as compared with WT human IL-18 with a KD for IL-18BP measured by SPR that is 10 nM or greater.
5 more elements
A method of making a polypeptide mimic of an interleukin 18 (IL-18) protein, or a nucleic acid encoding the polypeptide mimic, the method comprising:
- (a) computationally designing a polypeptide mimic by:
- (i) defining as a template a structure of an IL-18 protein in a complex with at least human IL-18Rα;
- (ii) designating one or more hotspots in the template based on binding sites in the complex;
- (iii) inputting the template comprising the one or more designated hotspots into a mimetic design protocol to identify a polypeptide mimic backbone comprising an immunoglobulin domain;
- and
- (iv) outputting an amino acid sequence for the designed polypeptide mimic;
- and
- (b) producing the polypeptide mimic, or a nucleic acid that encodes the polypeptide mimic, computationally designed in step (a), wherein the produced polypeptide mimic comprises the immunoglobulin domain and specifically binds to human IL-18 receptor (IL-18R), and the amino acid sequence of the polypeptide mimic has less than 50% sequence identity with wild-type human IL-18 SEQ ID NO:30.
5 more elements
Dependencies are inferred from the claim text.